Tahj Ra-El, a Purdue safety, was accused of leaking the Memphis playbook to UTSA's quarterback after he left the Tigers mid-season. Purdue said it "does not have any concerns" about Ra-El.

In 2024, the U.S. Supreme Court handed down a long-awaited ruling regarding the validity of nonconsensual third-party releases in the chapter 11 plan of pharmaceutical company Purdue Pharma, Inc ...

Alaska is set to receive up to $12.2 million over the next 15 years after signing onto a settlement with Purdue Pharma and the Sackler family The Sacklers’ former company, Purdue Pharma, made ...

The Supreme Court’s landmark 2024 Purdue Pharma decision altered the landscape for bankruptcy releases and, in the process, put the resolutions of several other pending mass tort chapter 11 ...

The NCAA is considering expanding the NCAA Tournament from 68 teams to 72 or 76 teams. Is it necessary? Will it help or hurt college basketball? Purdue coach Matt Painter offered his thoughts.

Expectations are high in West Lafayette as Purdue prepares for the 2025-26 season. With so much talent, many peg the Boilermakers as national title contenders.

Purdue ended paper distribution and parking passes for Exponent staff. IU rejected student-approved funding for the Indiana Daily Student.

Arkansas will receive $44.5 million of a $7.4 billion settlement with Purdue Pharma and the Sackler family for their role in the United States’ opioid epidemic. Arkansas Attorney General Tim ...

LITTLE ROCK (KATV) — Arkansas Attorney General Tim Griffin recently announced the results of the $7.4 billion settlement with Purdue Pharma and the Sackler family for their role in the ...

Arkansas Attorney General Tim Griffin announced that the state has received $44.5 million as part of a Purdue Pharma settlement.

Purdue Pharma, a Stamford-based drug maker that has faced billions in fines for misleading the public on its addictive opioid OxyContin, has received court approval to pay more than $7.4 billion ...

The Sackler family will now relinquish control of Purdue Pharma and cease sale of opioids in the U.S. as part of a $7.4 billion settlement.